Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD9 | Q9H8M2 | 1/20 | 0.35 |
| ▸ | BRD7 | Q9NPI1 | 1/20 | 0.35 |
| ▸ | BRD4 | O60885 | 1/20 | 0.34 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.34 |
| ▸ | KDR | P35968 | 1/20 | 0.34 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | HTR1A | P08908 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27500689 | 0.86 | KDR (0.38) | KDRMEN1KMT2A | |
| SCHEMBL27970546 | 0.83 | HTR1A (0.42) | HTR1A | |
| SCHEMBL3154256 | 0.82 | PDCD1 (0.38) | HTR1A | |
| SCHEMBL27171017 | 0.81 | CD274 (0.30) | — | |
| SCHEMBL14142022 | 0.81 | PTAFR (0.36) | HTR1A | |
| SCHEMBL3145664 | 0.81 | — | — | |
| SCHEMBL20165822 | 0.80 | MEN1 (0.33) | BRD9BRD7MEN1KMT2A | |
| SCHEMBL29776124 | 0.80 | HTR1A (0.46) | MEN1KMT2AHTR1A | |
| SCHEMBL3150842 | 0.78 | GSTP1 (0.42) | ACHE | |
| SCHEMBL30230061 | 0.78 | GSTP1 (0.42) | ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118184711-A | Process for preparing metallocene catalyst | 中国石油天然气股份有限公司 | 2024-06-14 | — | — | CN | claimed |
| US-12195563-B2 | Polyolefin-based ionomers and production thereof | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2025-01-14 | — | — | US | disclosed |
| CN-118184711-A | Process for preparing metallocene catalyst | 中国石油天然气股份有限公司 | 2024-06-14 | — | — | CN | disclosed |
| US-20240084056-A1 | Polyolefin-Based Ionomers and Production Thereof | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2024-03-14 | — | — | US | disclosed |
| EP-4271718-A1 | POLYOLEFIN-BASED IONOMERS AND PRODUCTION THEREOF | ExxonMobil Chemical Patents Inc. (US) | 2023-11-08 | — | — | EP | disclosed |
| CN-116670188-A | Polyolefin-based ionomers and preparation thereof | 埃克森美孚化学专利公司 | 2023-08-29 | — | — | CN | disclosed |
| CN-110177798-B | Catalyst and process for preparing same | 博里利斯股份公司 | 2022-08-30 | — | — | CN | disclosed |
| WO-2022146634-A1 | POLYOLEFIN-BASED IONOMERS AND PRODUCTION THEREOF | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2022-07-07 | — | — | WO | disclosed |
| US-20220213241-A1 | Polyolefin-Based Ionomers and Production Thereof | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2022-07-07 | — | — | US | disclosed |
| US-11352376-B2 | Catalysts | BOREALIS AG (AT) | 2022-06-07 | — | — | US | disclosed |
| EP-3541823-B1 | CATALYSTS | BOREALIS AG (AT) | 2020-12-30 | — | — | EP | disclosed |
| US-20190308995-A1 | CATALYSTS | BOREALIS AG (AT) | 2019-10-10 | — | — | US | disclosed |
| EP-3541823-A1 | CATALYSTS | Borealis AG (AT) | 2019-09-25 | — | — | EP | disclosed |
| WO-2018091684-A1 | CATALYSTS | BOREALIS AG (AT) | 2018-05-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11352376-B2 | Catalysts | SIGMAR1, H1-2, SFN | BRD9 1797/4885BRD7 2142/4885BRD4 1783/4885 |
| US-20190308995-A1 | CATALYSTS | SIGMAR1, H1-2, CBR1 | BRD9 1700/4885BRD7 2147/4885BRD4 1701/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.